In the past, control measures for leprosy were based on segregation of
infected patients combined with various palliative therapies. The dis
covery of powerful antibiotics effective in treating leprosy, and thei
r increased availability worldwide, have renewed hope for significant
changes in the global control of leprosy. Further optimism arises from
the demonstration of the protective efficacy of BCG vaccination again
st leprosy and the elucidation of cellular and molecular events associ
ated with the pathological changes during infection. A number of epide
miological problems remain - such as the precise mode of disease trans
mission and risk factors for contracting leprosy. Also needed to compl
ement current control strategies are better tools for diagnosing lepro
sy in its earliest stages and a concerted educational campaign aimed a
t eliminating the stigma associated with leprosy.